You have 9 free searches left this month | for more free features.

rintatolimod

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Post COVID-19 Condition, Long COVID Trial (Rintatolimod, Placebo / Normal Saline)

Not yet recruiting
  • Post COVID-19 Condition
  • Long COVID
  • Rintatolimod
  • Placebo / Normal Saline
  • (no location specified)
Oct 20, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Ovarian Cancer Recurrent Trial in Pittsburgh (Rintatolimod, Pembrolizumab, Cisplatin)

Recruiting
  • Ovarian Cancer Recurrent
  • Rintatolimod
  • +2 more
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital of UPMC
Mar 3, 2022

Pancreatic Cancer Trial (Rintatolimod)

Not yet recruiting
  • Pancreatic Cancer
  • Rintatolimod
  • (no location specified)
Aug 8, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer Trial in Seattle (HER-2/neu peptide vaccine,

Completed
  • HER2-positive Breast Cancer
  • +7 more
  • HER-2/neu peptide vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 4, 2020

Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial

Completed
  • Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
  • +2 more
  • DC vaccine
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 6, 2020